Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in India

Mankind Pharma partners with Takeda to introduce Vonoprazan for GERD, oesophagitis, ulcers, and Helicobacter pylori in India. EVP Ramesh stresses business growth. Collaborations with AstraZeneca (Symbicort) and Novartis (Neptaz) enhance their strategy. In-licensing, including royalties on sales, expands domestic formulations using local sales networks, improving access to innovative therapies.